Type i interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection

Cell Host and Microbe

Volumn 14, Issue 5, 2013, Pages 510-521

  Sanyal, Sumana ^a   Ashour, Joseph ^a   Maruyama, Takeshi ^a   Altenburg, Arwen F ^a   Cragnolini, Juan Jose ^a   Bilate, Angelina ^a   Avalos, Ana M ^a   Kundrat, Lenka ^a   García Sastre, Adolfo ^c   Ploegh, Hidde L ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCRT PROTEIN; GLYCOPROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; INTERFERON STIMULATED PROTEIN ISG15; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; GOLGI COMPLEX; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SECRETORY PATHWAY; VIRION; VIRUS ASSEMBLY; VIRUS RELEASE;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GLYCOPROTEINS; GOLGI APPARATUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INTERFERON TYPE I; TRANSCRIPTION FACTORS; UBIQUITINS; VIRUS RELEASE;

EID: 84887957632     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.10.011     Document Type: Article

References (44)

1. A.L. Brass, I.-C. Huang, Y. Benita, S.P. John, M.N. Krishnan, E.M. Feeley, B.J. Ryan, J.L. Weyer, L. van der Weyden, and E. Fikrig The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus Cell 139 2009 1243 1254
2. E.A. Bruce, L. Medcalf, C.M. Crump, S.L. Noton, A.D. Stuart, H.M. Wise, D. Elton, K. Bowers, and P. Digard Budding of filamentous and non-filamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway Virology 390 2009 268 278
3. E.A. Bruce, P. Digard, and A.D. Stuart The Rab11 pathway is required for influenza A virus budding and filament formation J. Virol. 84 2010 5848 5859
4. B.J. Chen, G.P. Leser, D. Jackson, and R.A. Lamb The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding J. Virol. 82 2008 10059 10070
5. L. Cong, F.A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P.D. Hsu, X. Wu, W. Jiang, L.A. Marraffini, and F. Zhang Multiplex genome engineering using CRISPR/Cas systems Science 339 2013 819 823
6. D. Cox, D.J. Lee, B.M. Dale, J. Calafat, and S. Greenberg A Rab11-containing rapidly recycling compartment in macrophages that promotes phagocytosis Proc. Natl. Acad. Sci. USA 97 2000 680 685
7. L. Diaz, J. Cassella, A. Bonavia, R. Duan, D. Santos, Z. Fesseha, M. Goldblatt, and M. Kinch Recruitment of the TSG101/ESCRT-I Machinery in Host Cells by Influenza Virus: Implications for Broad-Spectrum Therapy Antiviral Res. 82 2009 A71
8. A.J. Eisfeld, E. Kawakami, T. Watanabe, G. Neumann, and Y. Kawaoka RAB11A is essential for transport of the influenza virus genome to the plasma membrane J. Virol. 85 2011 6117 6126
9. R. Ernst, J.H.L. Claessen, B. Mueller, S. Sanyal, E. Spooner, A.G. van der Veen, O. Kirak, C.D. Schlieker, W.A. Weihofen, and H.L. Ploegh Enzymatic blockade of the ubiquitin-proteasome pathway PLoS Biol. 8 2011 e1000605
10. J.J. Flanagan, R.K. Tweten, A.E. Johnson, and A.P. Heuck Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding Biochemistry 48 2009 3977 3987
11. E.O. Freed HIV-1 and the host cell: an intimate association Trends Microbiol. 12 2004 170 177
12. N. Frias-Staheli, N.V. Giannakopoulos, M. Kikkert, S.L. Taylor, A. Bridgen, J. Paragas, J.A. Richt, R.R. Rowland, C.S. Schmaljohn, and D.J. Lenschow Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses Cell Host Microbe 2 2007 404 416
13. P.I. Hanson, and A. Cashikar Multivesicular body morphogenesis Annu. Rev. Cell Dev. Biol. 28 2012 337 362
14. T.-Y. Hsiang, C. Zhao, and R.M. Krug Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells J. Virol. 83 2009 5971 5977
15. W.Y. Hwang, Y. Fu, D. Reyon, M.L. Maeder, S.Q. Tsai, J.D. Sander, R.T. Peterson, J.-R.J. Yeh, and J.K. Joung Efficient genome editing in zebrafish using a CRISPR-Cas system Nat. Biotechnol. 31 2013 227 229
16. N. Jouvenet, S.M. Simon, and P.D. Bieniasz Visualizing HIV-1 assembly J. Mol. Biol. 410 2011 501 511
17. A. Karlas, N. Machuy, Y. Shin, K.-P. Pleissner, A. Artarini, D. Heuer, D. Becker, H. Khalil, L.A. Ogilvie, and S. Hess Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication Nature 463 2010 818 822
18. M.C.S. Lee, and E.A. Miller Molecular mechanisms of COPII vesicle formation Semin. Cell Dev. Biol. 18 2007 424 434
19. M.P. Malakhov, O.A. Malakhova, K.I. Kim, K.J. Ritchie, and D.-E. Zhang UBP43 (USP18) specifically removes ISG15 from conjugated proteins J. Biol. Chem. 277 2002 9976 9981
20. P. Mali, L. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, and G.M. Church RNA-guided human genome engineering via Cas9 Science 339 2013 823 826
21. J. Martin-Serrano, and S.J.D. Neil Host factors involved in retroviral budding and release Nat. Rev. Microbiol. 9 2011 519 531
22. J. Martin-Serrano, T. Zang, and P.D. Bieniasz HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress Nat. Med. 7 2001 1313 1319
23. A. Okumura, G. Lu, I. Pitha-Rowe, and P.M. Pitha Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15 Proc. Natl. Acad. Sci. USA 103 2006 1440 1445
24. A. Okumura, P.M. Pitha, and R.N. Harty ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity Proc. Natl. Acad. Sci. USA 105 2008 3974 3979
25. M.W. Popp, J.M. Antos, G.M. Grotenbreg, E. Spooner, and H.L. Ploegh Sortagging: a versatile method for protein labeling Nat. Chem. Biol. 3 2007 707 708
26. M.W.-L. Popp, J.M. Antos, and H.L. Ploegh Site-specific protein labeling via sortase-mediated transpeptidation Curr Protoc Protein Sci Chapter 15 2009 Unit15.3
27. M.W.-L. Popp, R.A. Karssemeijer, and H.L. Ploegh Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time PLoS Pathog. 8 2012 e1002604
28. M. Razi, and C.E. Futter Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation Mol. Biol. Cell 17 2006 3469 3483
29. J.S. Rossman, and R.A. Lamb Influenza virus assembly and budding Virology 411 2011 229 236
30. J.S. Rossman, X. Jing, G.P. Leser, and R.A. Lamb Influenza virus M2 protein mediates ESCRT-independent membrane scission Cell 142 2010 902 913
31. R.W.H. Ruigrok, A. Barge, P. Durrer, J. Brunner, K. Ma, and G.R. Whittaker Membrane interaction of influenza virus M1 protein Virology 267 2000 289 298
32. S. Sanyal, J.H.L. Claessen, and H.L. Ploegh A viral deubiquitylating enzyme restores dislocation of substrates from the endoplasmic reticulum (ER) in semi-intact cells J. Biol. Chem. 287 2012 23594 23603
33. A.P. Schmitt, and R.A. Lamb Influenza virus assembly and budding at the viral budozone Adv. Virus Res. 64 2005 383 416
34. E.J. Seo, and J. Leis Budding of Enveloped Viruses: Interferon-Induced ISG15-Antivirus Mechanisms Targeting the Release Process Adv. Virol. 2012 2012 532723
35. S.D. Shapira, I. Gat-Viks, B.O.V. Shum, A. Dricot, M.M. de Grace, L. Wu, P.B. Gupta, T. Hao, S.J. Silver, and D.E. Root A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection Cell 139 2009 1255 1267
36. B. Skaug, and Z.J. Chen Emerging role of ISG15 in antiviral immunity Cell 143 2010 187 190
37. F.G. Tafesse, S. Sanyal, J. Ashour, C.P. Guimaraes, M. Hermansson, P. Somerharju, and H.L. Ploegh Intact sphingomyelin biosynthetic pathway is essential for intracellular transport of influenza virus glycoproteins Proc. Natl. Acad. Sci. USA 110 2013 6406 6411
38. M. Tsurudome, R. Glück, R. Graf, R. Falchetto, U. Schaller, and J. Brunner Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion J. Biol. Chem. 267 1992 20225 20232
39. K.U. Wagner, A. Krempler, Y. Qi, K. Park, M.D. Henry, A.A. Triplett, G. Riedlinger, E.B. Rucker III, and L. Hennighausen Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues Mol. Cell. Biol. 23 2003 150 162
40. R. Watanabe, and R.A. Lamb Influenza virus budding does not require a functional AAA+ ATPase, VPS4 Virus Res. 153 2010 58 63
41. J.J. White, K.K. Matlin, and A.A. Helenius Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses J. Cell Biol. 89 1981 674 679
42. W. Yuan, and R.M. Krug Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein EMBO J. 20 2001 362 371
43. C. Zhao, T.-Y. Hsiang, R.-L. Kuo, and R.M. Krug ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells Proc. Natl. Acad. Sci. USA 107 2010 2253 2258
44. C. Zhao, M.N. Collins, T.-Y. Hsiang, and R.M. Krug Interferon-induced ISG15 pathway: an ongoing virus-host battle Trends Microbiol. 21 2013 181 186